REFERENCES
- Chern JP, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD, et al. Abnormal glucose tolerance in transfusion-dependent β thalassemic patients. Diabetes Care. 2001; β24(5)850–854
- Christoforidis A, Perifanis V, Tsatra I, Vlachaki E, Athanassiou-Metaxa M. Evolution of OGTT in patients with β-thalassaemia major in relation to chelation therapy. Diabetes Res Clin Pract. 2007; 76(1)6–11
- Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and β-cell secretion in thalassaemia major with secondary haemochromatosis: Assessment by oral glucose tolerance test. Eur J Pediatr. 2003; 162(3)139–146
- Suvarna J, Ingle H, Deshmukh CT. Insulin resistance and β cell function in chronically transfused patients of thalassemia major. Indian Pediatr. 2006; 43(5)393–400
- Mowla A, Karimi M, Afrasiabi A, De Sanctis V. Prevalence of diabetes mellitus and impaired glucose tolerance in β-thalassemia patients with and without hepatitis C virus infection. Pediatr Endocrinol Rev. 2004; 2(Suppl. 2)282–284
- Mangiagli A, Campisi S, De Sanctis V, Caruso Nicoletti M, Cardinale G, Galati MC, et al. Study Group of the Italian Pediatric and Diabetes Society (SIEDP) on Endocrine Complications in Non-Endocrince Disease. Effects of acarbose in β-thalassaemia major patients with normal glucose tolerance and hyperinsulinism. Pediatr Endocrinol Rev. 2004; 2(Suppl. 2)272–275
- Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften TW, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000; 23(3)295–301
- American Diabetes Association (ADA). Screening for Type 2 Diabetes. Diabetes Care. 2004; 27(Suppl. 1)S11–S14
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985; 28(7)412–419
- Dawson B, Trapp RG. Basic and Clinical Biostatistics. Lange Medical Books-McGraw-Hill, New York 2001; 3rd
- Schianca GPC, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance. Importance of insulin secretion and resistance. Diabetes Care. 2003; 26(5)1333–1337
- Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: Incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center. Pediatr Endocrinol Rev. 2004; 2(Suppl. 2)285–291
- Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, et al. Validation of the insulin sensitivity index (ISI (0, 120)): Comparison with other measures. Diabetes Res Clin Pract 2000; 47(3)166–184
- Angelopoulos NG, Zervas A, Livadas S, Adamopoulos I, Giannopoulos D, Goula A, et al. Reduced insulin secretion in normoglycaemic patients with β-thalassaemia major. Diabet Med. 2006; 23(12)1327–1331
- Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L, et al. Insulin resistance and hyperinsulinemia in homozygous β-thalassemia. Metabolism. 1995; 44(3)281–286
- Messina MF, Lombardo F, Meo A, Miceli M, Wasniewska M, Valenzise M, et al. Three-year prospective evaluation of glucose tolerance, β-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major. J Endocrinol Invest. 2002; 25(6)497–501
- Skordis N, Michaelidou M, Savva SC, Ioannou Y, Rousounides A, Kleanthous M, et al. The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol. 2006; 77(2)150–156
- Fernnadez-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998; 21(1)62–68
- Farmaki K, Angelopoulos N, Anagnostopoulos G, Gotsis E, Rombopoulos G, Tolis G. Effect of enhanced iron chelation therapy on glucose metabolism in patients with β-thalassaemia major. Br J Haematol. 2006; 134(4)438–444